drugset
drugset / Trial / NCT00241605

AVANDAMET Versus Metformin For Type 2 Diabetes Mellitus

NCT00241605 ↗

Phase 4 Completed 600 enrolled GlaxoSmithKline
RandomizedParallel-groupOpen-labelTreatment

Summary

This 48-week study will compare AVANDAMET vs. Metformin monotherapy for blood glucose control in patients with Type 2 Diabetes Mellitus.

Timeline

Start
2003-06-25
Primary completion
2005-12-01
Completion
2005-12-16

Drugs

EvaluationDrugModalityDoseRoute
Subject rosiglitazone/metformin Unknown — —

Indications

type 2 diabetes mellitus